genOway
Created in 1999
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
661 6,223Activities
Technologies
Entity types
Location
31 Rue Saint-Jean-de-Dieu, 69007 Lyon, France
Lyon
France
Employees
Scale: 51-200
Estimated: 114
SIREN
422123125Engaged corporates
7
3 3Added in Motherbase
5 years, 5 months ago
biotech Value proposition
Ultimate predictability
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy.
genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate.
Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.
Genetically modified mouse, rat and cell models, Knockout, Knockin, Point mutation, Humanization, Inducible systems, etc., CRISPR/Cas9, homologous recombination, RMCE, targeted transgenesis, etc., Off-the-shelf catalog mouse models, Immunology, Immunotherapy, Oncology, Immuno-oncology, License, Preclinical models, Cancer Research, Fundamental research, Clinical research, and Freedom to operateOriginal language
Ultimate predictability
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy.
genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate.
Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.
Preclinical mouse, rat & cell lines for ultimate predictability | genOway
genOway offers preclinical models and solutions to bio-pharmaceutical and academic researchers for ultimate predictability.
https://www.genoway.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 21 Nov 2024 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Dec 2024 | | |
 Auvergne-Rhone-Alpes Entreprises - Isère National and local authorities, Business Consulting and Services | Auvergne-Rhone-Alpes Entreprises - Isère National and local authorities, Business Consulting and Services | Other 31 Jul 2024 | | |
 LDLC Consumer Electronics, Computers and Electronics Manufacturing | LDLC Consumer Electronics, Computers and Electronics Manufacturing | Capitalistic Not partnership Event 15 Sep 2020 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 15 Jan 2019 19 Sep 2022 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 2 Sep 2024 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Not capitalistic Not partnership Event 28 May 2021 | | |